Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
09/2014
09/18/2014US20140275545 8-carboxamido-2,6-methano-3-benzazocines
09/18/2014US20140275542 Synthesis of a serotonin reuptake inhibitor
09/18/2014US20140275531 Substituted pyridine and pyrazine compounds as pde4 inhibitors
09/18/2014US20140275529 Subunit selective nmda receptor potentiators for the treatment of neurological conditions
09/18/2014US20140275185 Novel S-Nitrosoglutathione Reductase Inhibitors
09/18/2014US20140275176 Compounds and uses thereof for the modulation of hemoglobin
09/18/2014US20140275174 TREATMENT OF OVARIAN CANCER WITH 2-AMINO-4H-NAPHTHO[1,2-b]PYRAN-3-CARBONITRILES
09/18/2014US20140275172 Benzo-fused heterocyclic derivatives useful as agonists of gpr120
09/18/2014US20140275171 Macrocyclic picolinamides as fungicides
09/18/2014US20140275158 Cyclohexyl isoquinolinone compounds
09/18/2014US20140275155 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275132 Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators
09/18/2014US20140275115 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
09/18/2014US20140275114 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275112 Compounds For Stabilizing Ryanodine Receptors From Aberrant Levels Of Calcium Release
09/18/2014US20140275086 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/18/2014US20140275085 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities
09/18/2014US20140275081 Inhibitors of human ezh2, and methods of use thereof
09/18/2014US20140275080 N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
09/18/2014US20140275079 Pyrrole amide inhibitors
09/18/2014US20140275077 Uracil derivatives as axl and c-met kinase inhibitors
09/18/2014US20140275068 Pro-drug compounds
09/18/2014US20140275059 Dna-pk inhibitors
09/18/2014US20140275028 1,2,5-substituted benzimidazoles as flap modulators
09/18/2014US20140275025 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275024 Dna-pk inhibitors
09/18/2014US20140275020 Inhibitors of the renal outer medullary potassium channel
09/18/2014US20140275016 N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
09/18/2014US20140275011 Pyridine cdk9 kinase inhibitors
09/18/2014US20140275010 Quaternary salts
09/18/2014US20140275005 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
09/18/2014US20140274960 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
09/17/2014EP2778165A1 Synthesis of a serotonin reuptake inhibitor
09/17/2014EP2778164A1 Method for producing 4-benzyl-1-methyl-6-oxabicyclo[3,2,0]heptane derivative and method for producing azole derivative
09/17/2014EP2776438A1 Substituted purine nucleosides, phosphoramidate and phosphordiamidate derivatives for treatment of viral infections
09/17/2014EP2776427A1 Modulators of atp-binding cassette transporters
09/17/2014EP2776405A1 2-thiopyrimidinones
09/17/2014EP2776403A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators
09/17/2014EP2776396A2 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
09/16/2014US8835693 Migrastatin analogs and uses thereof
09/16/2014US8835659 Polysubstituted benzofurans and medicinal applications thereof
09/16/2014US8835641 Fluorescent markers and use thereof for labeling specific protein targets
09/16/2014US8835635 Amorphous form of vilazodone hydrochloride substantially free of crystalline forms
09/16/2014US8835634 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
09/16/2014US8835491 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
09/16/2014US8835488 Opioid receptor ligands and methods of using and making same
09/16/2014US8835472 Compounds, pharmaceutical compositions and uses thereof
09/16/2014US8835462 Macrocyclic picolinamides as fungicides
09/16/2014US8835444 Cyclohexyl amide derivatives as CRF receptor antagonists
09/16/2014US8835440 Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD
09/16/2014US8835436 Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
09/16/2014US8835430 2,4-pyrimidinediamine compounds and their uses
09/16/2014US8835419 Substituted anilines as CCR(4) antagonists
09/16/2014US8835418 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
09/16/2014CA2750864C Bis-aryl amide compounds and methods of use
09/12/2014WO2014138053A1 Neprilysin inhibitors
09/12/2014WO2014135955A1 Pyrimidine carboxamides as sodium channel blockers
09/12/2014WO2014135674A1 Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
09/12/2014WO2014135588A1 Alkoximino-substituted anthranilic acid diamides as pesticides
09/12/2014WO2014135495A1 Antiviral compounds
09/12/2014WO2014135422A1 Antiviral compounds
09/12/2014WO2014135414A1 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
09/11/2014US20140256949 Quinolyl amines as kinase inhibitors
09/11/2014US20140256780 Pyrazole derivatives as modulators of hepatocyte growth factor (scatter factor) activity
09/11/2014US20140256759 Kinase inhibitor and method for treatment of related diseases
09/11/2014US20140256753 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections
09/11/2014US20140256747 Synthesis of Triazolopyrimidine Compounds
09/11/2014US20140256745 Compounds that modulate intracellular calcium
09/11/2014US20140256727 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/11/2014US20140256725 Fsh receptor antagonists
09/11/2014US20140256708 1,3 substituted azetidine pde10 inhibitors
09/11/2014US20140256700 Carbazole compounds useful as bromodomain inhibitors
09/11/2014US20140256685 Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
09/11/2014US20140256684 Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
09/11/2014US20140256654 Bifunctional compounds
09/11/2014US20140255386 Microrna modulators and method for identifying and using the same
09/10/2014EP2774929A1 Isocyanurate epoxy compound having alkoxysilyl group, method of preparing same, composition including same, cured product of the composition, and use of the composition
09/10/2014EP2774925A1 Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters
09/10/2014EP2774917A1 Pharmaceutical composition for treating diabetes
09/10/2014EP2773642A1 Pak inhibitors for the treatment of cell proliferative disorders
09/10/2014EP2773634A1 Rod -like hepatitis c virus inhibitors containing the fragement {2- [4- (bi phenyl - 4 - yl) - 1h - imidazo - 2 - yl]pyrrolidine - 1 - carbonlymethyl} amine
09/10/2014EP2773632A1 8-fluorophthalazin-1 (2h) - one compounds as inhibitors of btk activity
09/10/2014EP2773631A1 Pesticidal compounds
09/09/2014US8829204 Modulators of ATP-binding cassette transporters
09/09/2014US8829200 Benzimidazole inhibitors of leukotriene production
09/09/2014US8829199 Aminopyrazole derivative
09/09/2014US8829195 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
09/09/2014US8829187 Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase
09/09/2014US8829035 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
09/09/2014US8829034 Compounds which modulate the CB2 receptor
09/09/2014US8829028 5-HT4 receptor antagonists for the treatment of heart failure
09/09/2014US8829026 Sulfamoyl benzoic acid heterobicyclic derivatives as TRPM8 antagonists
09/09/2014US8828973 Compounds as receptor modulators with therapeutic utility
09/09/2014US8828558 Monoamine compound, charge transport material, composition for charge transport film, organic electroluminescent element, organic EL display, and organic EL lighting
09/09/2014CA2802130C Cyanoquinoline derivatives
09/09/2014CA2671970C 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
09/09/2014CA2617282C Novel imidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
09/09/2014CA2516931C Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
09/04/2014WO2014134388A1 Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
09/04/2014US20140249319 Chemical crosslinkers and compositions thereof
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 694